LCM
BLU

Laurion Capital Management’s BELLUS Health Inc. BLU Stock Holding History

Laurion Capital Management’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,833,580
Closed -$34.8M – 715
2023
Q1 		$34.8M Buy
4,833,580
+3,281,614
+211% +$25.5M 0.24% 97
2022
Q4 		$12.8M Sell
1,551,966
-46,679
-3% -$435K 0.06% 209
2022
Q3 		$16.9M Sell
1,598,645
-3,715,694
-70% -$39.5M 0.1% 152
2022
Q2 		$49.1M Buy
5,314,339
+300,000
+6% +$2.45M 0.76% 29
2022
Q1 		$34.5M Buy
5,014,339
+1,270,220
+34% +$8.18M 0.42% 53
2021
Q4 		$30.1M Buy
3,744,119
+1,132,500
+43% +$7.52M 0.3% 57
2021
Q3 		$16M Sell
2,611,619
-402,000
-13% -$1.52M 0.07% 227
2021
Q2 		$9.37M Buy
3,013,619
+100,000
+3% +$382K 0.05% 220
2021
Q1 		$11.2M Buy
2,913,619
+2,813,619
+2,814% +$10.7M 0.06% 241
2020
Q4 		$306K Buy
+100,000
New +$271K ﹤0.01% 542

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Laurion Capital Management's BLU Position: Q2 2023 in Review

Laurion Capital Management sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 4,833,580 shares — an estimated $34.8M sold.

Laurion Capital Management first reported a position in BLU in Q4 2020 and held it in 10 quarters. The position peaked at $49.1M in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Laurion Capital Management reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Laurion Capital Management sold 4,833,580 BELLUS Health Inc. shares in Q2 2023, an estimated $34.8M.
  • Laurion Capital Management first reported a position in BELLUS Health Inc. in Q4 2020 and held it in 10 quarters.
  • Laurion Capital Management's BELLUS Health Inc. position peaked at $49.1M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.